Ditchcarbon
  • Contact
  1. Organizations
  2. Galderma International S.A.S
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated a month ago

Galderma International S.A.S Sustainability Profile

Company website

Galderma International S.A.S., headquartered in France, is a leading global player in the dermatology and aesthetic medicine industry. Founded in 1981, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. Galderma is renowned for its innovative products and services, focusing on skin health, medical dermatology, and aesthetic solutions. Its core offerings include the popular Restylane® range of dermal fillers and the Sculptra® collagen-stimulating injectable, both of which are distinguished by their unique formulations and proven efficacy. With a commitment to advancing dermatological science, Galderma has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and patients alike. The company continues to lead the market with its dedication to research and development, ensuring it remains at the forefront of the industry.

DitchCarbon Score

How does Galderma International S.A.S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Galderma International S.A.S's score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Galderma International S.A.S's reported carbon emissions

Inherited from Galderma Group AG

Galderma International S.A.S, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Galderma Group AG, which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, Galderma International S.A.S is part of a broader corporate family that may have established climate initiatives. However, no specific reduction targets or commitments have been documented for Galderma International S.A.S, nor are there any climate pledges or SBTi (Science Based Targets initiative) targets reported. As a subsidiary, Galderma International S.A.S may align its environmental strategies with those of its parent company, Galderma Group AG, but specific details on emissions or climate commitments are not available at this time. The absence of reported data suggests that the company may still be in the process of developing its climate strategy or reporting framework.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
9,800,000
0,000,000
Scope 2
4,200,000
000,000
Scope 3
-
000,000,000

How Carbon Intensive is Galderma International S.A.S's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma International S.A.S's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Galderma International S.A.S's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma International S.A.S is in FR, which has a very low grid carbon intensity relative to other regions.

Galderma International S.A.S's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Galderma International S.A.S has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Galderma International S.A.S's Emissions with Industry Peers

SciVision Biotech Inc.

TW
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Merz Pharmaceuticals GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Allergan, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy